Regional Business Manager - Southern Texas, TX
Intellia Therapeutics, Inc.
July 01, 2026
On-site
Cambridge, MA
Sales
Responsibilities
- Develop and execute comprehensive territory plans for immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers (Southern Texas, TX).
- Identify and prioritize high-value accounts (HAE patient volume, prescriber influence, institutional capabilities).
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers.
- Maintain robust sales pipeline from initial awareness through patient treatment completion.
- Educate providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo therapies and traditional treatments.
- Clearly articulate MOA versus prophylactic treatments, complement inhibitors, and plasma-derived therapies.
- Present Phase III efficacy and safety data.
- Address CRISPR safety misconceptions and differentiate from previous gene therapy launches.
- Educate on unmet needs, patient pathway (diagnosis confirmation to treatment administration), and coordinate hub services to ensure access.
- Maintain competitive intelligence and develop differentiated value propositions; handle objections about CRISPR, permanent genetic modification, and single-treatment cost.
- Partner with Medical Science Liaisons, Field Reimbursement Managers (payer strategy/coverage), and Strategic Accounts (referrals, site selection/activation).
Qualifications / Skills
- BS/BA in life sciences or business-related field.
- Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet needs.
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements.
- Ability to analyze/present complex clinical trial data and real-world evidence.
- Exceptional scientific communication; strong stakeholder relationship management.
- Proven specialty pharmaceutical sales experience (5+ years), preferably rare diseases/immunology/genetic medicines; rare disease commercialization and first-in-class/novel mechanism launch experience preferred.
- Experience with long sales cycles (12–18 months) and complex stakeholder environments.
Application instructions
- Applications accepted on a rolling basis until position is filled.
- Develop and execute comprehensive territory plans for immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers (Southern Texas, TX).
- Identify and prioritize high-value accounts (HAE patient volume, prescriber influence, institutional capabilities).
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers.
- Maintain robust sales pipeline from initial awareness through patient treatment completion.
- Educate providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo therapies and traditional treatments.
- Clearly articulate MOA versus prophylactic treatments, complement inhibitors, and plasma-derived therapies.
- Present Phase III efficacy and safety data.
- Address CRISPR safety misconceptions and differentiate from previous gene therapy launches.
- Educate on unmet needs, patient pathway (diagnosis confirmation to treatment administration), and coordinate hub services to ensure access.
- Maintain competitive intelligence and develop differentiated value propositions; handle objections about CRISPR, permanent genetic modification, and single-treatment cost.
- Partner with Medical Science Liaisons, Field Reimbursement Managers (payer strategy/coverage), and Strategic Accounts (referrals, site selection/activation).
Qualifications / Skills
- BS/BA in life sciences or business-related field.
- Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet needs.
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements.
- Ability to analyze/present complex clinical trial data and real-world evidence.
- Exceptional scientific communication; strong stakeholder relationship management.
- Proven specialty pharmaceutical sales experience (5+ years), preferably rare diseases/immunology/genetic medicines; rare disease commercialization and first-in-class/novel mechanism launch experience preferred.
- Experience with long sales cycles (12–18 months) and complex stakeholder environments.
Application instructions
- Applications accepted on a rolling basis until position is filled.